PRINCETON, N.J., June 23, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today 100% protection of non-human primates (NHPs) against lethal Marburg marburgvirus (MARV) challenge using… Read More..

Founder Steve Morris, appointed Chief Platform Officer to steer Bubblr's platform and data privacy efforts  NEW YORK, NY, June 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire– Bubblr Inc., (OTC PINK: BBLR), ("Bubblr" or the "Company"), the company making ethically-based Web3 development tools more accessible to programmers, companies and investors via… Read More..

As the rare disease drug development landscape continues to evolve, Quoin (NASDAQ: QNRX) is focused on staying ahead of its competitors. New York, New York--(Newsfile Corp. - June 14, 2022) - PCG Digital -- The life sciences industry has always been dynamic; a collective of organizations from small and agile… Read More..